glp-1 receptor meds Agonists: A Comprehensive Overview Is GLP-1 Safe for Weight

Even minor structural variations in peptide therapeutics can potentially impact efficacy, pharmacokinetics, immunogenicity, and long-term product stability, potentially leading to biosimilar comparability failure if not properly characterized

Subgroup analyses indicated reduced risks of colorectal cancer (HR 0.81: 95% CI: 0.680.96) and liver cancer (HR: 0.74

This article explains what's happening in the gut and why these changes matter for your patients.

Obesity 31 , 21712177 (2023)

Associations Between Weight Loss and Gastrointestinal Adverse Events on GLP-1RA Therapy While gastrointestinal adverse events that occur with GLP-1RAs are mainly mild-to-moderate and transient, occurring particularly during dose escalation, there may be concerns that GLP-1RA-mediated weight loss could be due to these effects